SUBCHAPTER 32u - Pharmacists vaccinations and administration of long-acting injectables

SECTION .0100 - pharmacists vaccinations and adminstration of long-acting injectables

21 NCAC 32U .0101         ADMINISTRATION OF VACCINES BY PHARMACISTS

Pharmacist personnel may administer vaccines in accordance with 21 NCAC 46 .2507.

History Note:        Authority G.S. 90-85.3(r); 90-85.15B; S.L. 2021-110;

Emergency Adoption Eff. September 10, 2004;

Temporary Adoption Eff. December 29, 2004;

Eff. November 1, 2005;

Amended Eff. February 1, 2008;

Emergency Amendment Eff. October 9, 2009;

Temporary Amendment Eff. December 29, 2009;

Temporary Amendment Expired on October 12, 2010;

Amended Eff. September 1, 2014; March 1, 2012;

Pursuant to G.S. 150B-21.3A rule is necessary without substantive public interest Eff. March 1, 2016;

Amended Eff. July 1, 2022.

21 NCAC 32U .0102         ADMINISRATION OF LONG-ACTING INJECTABLES

Pharmacists may administer long-acting injectables in accordance with 21 NCAC 46 .2514.

History Note:        Authority G.S. 90-85.15B; S.L. 2021-110;

Eff. July 1, 2022.

SUBCHAPTER 32u - Pharmacists vaccinations and administration of long-acting injectables

SECTION .0100 - pharmacists vaccinations and adminstration of long-acting injectables

21 NCAC 32U .0103         influenza test and treat

Pharmacists may, in accordance with 21 NCAC 46 .2517, initiate Clinical Laboratory Improvement Amendments waived testing and treatment for influenza, as defined in G.S. 90-85.3(b2), per the protocols available at the Board of Pharmacy's office and on its website, (www.ncbop.org/protocols), including prophylactic treatment for high-risk patients who have been exposed to influenza, as set forth in the protocols.

History Note:        Authority G.S. 90-85.3(b2), S.L. 2025-37, s. 5.3;

Eff. August 1, 2026.